期刊文献+

小鼠乳腺癌生长与肺转移关系研究 被引量:1

The study on development of implanted breast cancer and lung metastasis in mouse
下载PDF
导出
摘要 目的 :小鼠转移性乳腺癌的发展与肺转移的关系。方法 :应用流式细胞仪 (Flowcytometry,FCM)动态检测小鼠移植性乳腺癌细胞DNA指数 (DNAindex ,DI)、S期细胞百分率 (S - phasefraction ,SPF)、DNA倍体 ,并分析上述3种指标与移植天数及肺转移的关系。结果 :⑴SPF随移植天数增加而减少 ,二者间呈负的直线关系 (r= -0.611,P=0.014)。⑵肺转移前后DI有显著性差异 ,肺转移前DI高于肺转移后DI。⑶小鼠移植瘤的DI与移植天数间无直线关系 ,但存在一个趋势即自移植后第10日起DI呈上升趋势直至第36天 ,而后逐渐下降至实验结束。⑷肺转移前后SPF无显著性差异。⑸DNA倍体在肺转移前多表现为二倍体 ,在肺转移后表现为异倍体 ,后期又表现为二倍体。结论 :用流式细胞仪分析小鼠移植性乳腺癌生长与肺转移的关系对临床研究有重要的意义。 Objective:To study the relationship between development of breast cancer and lung metastasis in mouse.Methods:DNA ploid,DNA index(DI)and s-phase fraction(SPF)were tested consecatively in implanted murine breast cancer cells using FCM,their relationship with the implanting days and development of lung metastasis was analyzed.Results:①SPF deˉcreased as the implanted tumors grew.That was significant in statistics(r=-0.661,P=0.014).②Higher DI was observed in groups before lung metastasis developed.(1.1913±0.2903vs0.7118±0.1185,P=0.005).③DI of implanted tumors in mouse increased from the10th day after implanting until the36th day.Then,it began to decrease gradually but no statistic significance.④Though there was no significant difference between SPF before and after lung metastasis happened,it was found that higher SPF was observed before lung metasˉtasis developed.⑤Most implanted tumors in mouse were diploid(6/8)before lung metastasis happened,while after that,they turned aneuploid and then diploid again until the experiment ended.Conclusion:It is important for clinical study to analyze the relationship between develˉopment of implanted murine breast cancer and its lung metastasis using FCM.
作者 张敏 宁连胜
出处 《天津医科大学学报》 2003年第1期66-68,共3页 Journal of Tianjin Medical University
关键词 流式细胞仪 小鼠移植性乳腺癌 生长 进展 肺转移 Flow cytometry Implanted breast cancer in mouse Development Progressio_ n Lung metastasis
  • 相关文献

参考文献4

二级参考文献6

共引文献10

同被引文献27

  • 1王芬.培植牛黄抗氧化作用的研究[J].辽宁中医杂志,2005,32(1):73-73. 被引量:4
  • 2周萍,章岳山.紫杉醇单药治疗乳腺癌肺转移16例疗效观察[J].肿瘤学杂志,2006,12(2):139-140. 被引量:3
  • 3Schl.,OK,徐志强.乳腺癌肺转移的临床病程[J].德国医学,1990,7(2):94-95. 被引量:4
  • 4陈前军,陆德铭,司徒红林,任黎萍,关若丹,徐飚,林毅.“乳宁Ⅱ号”抑制Ca761小鼠乳腺癌肺转移及其对nm23、Cath-D表达的影响[J].中国中医基础医学杂志,2007,13(7):523-524. 被引量:5
  • 5顾林,王平.乳腺癌.北京:科学技术文献出版社,2010,1:2.
  • 6Clark GM,Sledge GW,Osborne J CK,et al. Survival from first re- currence: relative importance of prognostic factors in 1015 breast cancer patients[J]. J Clin Oncol, 1987,5 : 55.
  • 7Kang Hs,Youn YK,Oh SK. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer [J]. Breast Cancer Res Treat,2000,6(1 ) :81.
  • 8Julie L,Jordan A,Nowak Lee. Activation of innate immunity to reduce lung metastases in breast cancer Cancer. Immunology Im- munotherapy, 2010,59 (5) :789-797.
  • 9Jiang J,Thyagarajan-Sahu A,Loganathan J,et al. BreastDefendTM prevents breast-to-lung cancer metastases in an orthotopic ani- mal model of triple-negative human breast cancer[J]. Oncol Rep, 2012,28(4) : 1139-1145.
  • 10Brunelli M ,Manfrin E, Martignoni G,et al. HER2/neuassessment in breast cancer using the original FDA and newASCO/CAP guide- line recommendations: impact on selecting'patients for herceptin therapy[J].Am J Clin Pathol, 2008,129 ( 6 ) : 907 -911.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部